Factors associated with anxiety symptoms in people living in France with chronic disease or disability during the 2020-2023 COVID-19 pandemic
Background: Individuals with chronic disease or disability (CDD) were particularly vulnerable to mental health issues during the COVID-19 health crisis. This study aimed to assess the association between anxiety symptoms and the severity of non-pharmaceutical interventions (NPIs)
Background: Individuals with chronic disease or disability (CDD) were particularly vulnerable to mental health issues during the COVID-19 health crisis. This study aimed to assess the association between anxiety symptoms and the severity of non-pharmaceutical interventions (NPIs) during the COVID-19 health crisis in France, and to identify factors influencing anxiety levels among people with CDD. Methods: We conducted a monthly longitudinal survey between 20 May 2020 and 31 May 2023 among volunteer participants with CDD recruited by health association networks. Anxiety was measured using the Generalized Anxiety Disorder scale (GAD-7). Each of 11 pandemic periods was assigned a ‘NPI severity’ level, ranging from 0 (least restrictive) to 4 (most restrictive). Results: A total of 3713 individuals with CDD completed 41,678 questionnaires. Anxiety symptoms (GAD-7 ≥ 8), included mild-to-moderate symptoms, were associated with several NPIs severity levels, with an odds ratio of 1.22 (95%CI: [1.10 - 1.35]) for NPI level 2, 1.49 (95% CI: [1.34 - 1.66]) for level 3, and 1.38 (95%CI: [1.23 - 1.55]) for level 4, compared to level 0. Women, people aged 18–49 years, individuals with low socioeconomic status, multiple comorbidities, and difficulties with continuity of care, had a higher risk of anxiety symptoms. Limitations: The results cannot be generalized to the entire French CDD population and no pre-crisis data were available for comparison. Conclusion: Our study highlights a link between NPIs severity during the COVID-19 health crisis and the risk of anxiety symptoms in individuals with CDD. The psychological effects of NPIs should be considered in future pandemic interventions.
Auteur(s) : Balestier Anita, Cassagne Etienne, Segala Claire, Fosse Sandrine, Guillot Caroline, El Yamani Mounia
Année de publication : 2026
Pages : 101075
Site web de l'éditeurEn relation avec
Nos dernières actualités
actualité
10 juillet 2026Se baigner en toute sécurité en adoptant les bons gestes
actualité
9 juillet 2026Santé publique France publie son Rapport annuel 2025 : 10 ans d’engagement...
actualité
3 juillet 2026Point de situation sur la mortalité toutes causes confondues sur la période...
Need mental health in Europe?
Browse verified clinics with transparent pricing and real reviews across 30+ countries.
Source.
Santé publique France — Santé publique France, sous licence ouverte 2.0
Medical disclaimer.
Articles are general information aggregated from third-party medical sources. They are NOT a substitute for in-person diagnosis or treatment. For personal medical guidance, consult a verified clinician or call your local emergency line (112 in the EU).